Date: 5-6 September 2022
Location: Geneva, Switzerland
Organiser
Paediatric working group, ESCMID Study Group for Antimicrobial Stewardship (ESGAP)
Module objectives
Although providing advice on the management of children with infections (both common and complex infections) falls within the routine workload of clinical microbiologists and antimicrobial pharmacists working in general hospitals across Europe, there are many fundamental differences between adults and children that impact on decision making. Not only are children vulnerable to a number of pathologies that most adults are protected from, the aetiology and presentation of infection in children often differs considerably. Sample collection in children can be extremely challenging and the effect of the microbiota can limit the utility of many tests in children. For these reasons, many microbiologists and clinical pharmacists feel less confident proving advice on children compared to adults, potentially resulting in unnecessary investigations, prolonged exposure to antimicrobials and diagnostic delays. This course aims to address some of these issues through a series of case-based interactive workshops. Active participation will be maintained through on-line discussions and real-time voting. Key differences between children and adults will be highlighted and evidence based approaches to managing children will be presented. Discussions within these workshops will include the role of lumbar puncture in young infants with UTIs, conservative versus surgical management of atypical mycobacterial lymphadenitis in children, the role of pneumococcal urinary antigen testing in children with pneumonia, whether routine echocardiography is required in all children with staph aureus bacteraemia, investigating the baby with late onset sepsis, managing children following a significant exposure to pulmonary TB and many others. This approach has been used annually at the annual UK Federation of Infection Society (FIS) meeting and has received excellent feedback from microbiologists.
Preliminary programme
Date: 23-25 January 2023
Location: Online
Organisers
Bichat Claude Bernard Hospital, University of Paris, IAME, Inserm; in partnership with Doctors Without Borders (MSF), Imperial College London, United Kingdom, University of Cape Town, South Africa and University of Bobo Dioulasso, Burkina Faso
Module objectives
Understand the issues and challenges of AMS in LMICs, to enable participants to better adapt the concepts learned in the other modules to these specific contexts, based on the example of several specific initiatives and solutions. The module will cover three themes: the context (Epidemiology of AMR and Antimicrobial prescription in LMICs); the implementation of AMS programs in LMICs; and the perspectives (researches, innovations, and training programs). This is aimed either at participants wishing to practice directly in these fields, or at those working on global health issues.
Preliminary programme
Date: 17-19 March 2023
Location: Homburg/Saar, Germany
Organisers
Institute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany
Module objectives
Processes of globalisation and climate change have far-reaching consequences, which affect medical care worldwide. Steadily rising temperatures and climate change-induced natural disasters lead to changing mobility patterns and migration movements of refugees. Furthermore, infectious diseases may become prevalent in regions that have not been affected previously. Antimicrobial stewardship, especially for migration- and travel-associated infections, should therefore be taught with a global and holistic perspective, taking medical, political, and cultural factors into account. The aims of the course are to (i) enable participants to diagnose and classify infectious diseases in the context of travel and migration, (ii) develop diagnostic strategies and treatment options for selected travel- and migration-associated infections, and (iii) apply the AMS concept specifically to health problems associated with migration, One Health and climate change.
Preliminary programme
Date: 10-12 May 2023
Location: Seville, Spain
Organisers
Hospital Universitario Virgen Macarena
Module objectives
1. To learn how an antimicrobial stewardship programme (ASP) was designed
and implemented in a specific setting (University hospital with a low rate of multidrug-resistant
organisms [MDRO] located in Southern Europe)
2. To observe and learn how the ASP interventions are performed in real life in the different clinical settings and scenarios, with the
available resources
3. To discuss how to measure the impact of the interventions
4. To understand the importance of the synergy between infection control and ASP
Preliminary programme
Date: 15-16 June 2023
Location: Lille, France
Organisers
University hospital of Poitiers / University hospital of Lille
Module objectives
The aim of the module is to ensure an understanding of:
- Pharmacokinetics: knows and understands the pharmacokinetics of antibiotics related to AMS
- Extracellular/intracellular distribution of antimicrobials and its implication for antibiotic prescribing
- Pharmacodynamics: knows the mechanism of action of antimicrobials, their clinically relevant antimicrobial spectra, and understands the pharmacodynamics properties important for antimicrobial dosing
- Allergy: knows and understands the pathogenesis of allergy to antimicrobials and its clinical presentation, and can plan the therapy to avoid the risk of allergy, knows the principles of de-labelling and as a leader be capable of organizing de-labelling in their setting
- Availability of antimicrobials: knows the antimicrobials listed in the formulary in his setting and their trade names, contributes to proper inclusion of new antimicrobial drugs in the formulary, knows the risks of drug shortages and is capable to respond to the shortages according to the setting
- The dose / dosing interval (incl. prolonged and continuous infusion): understands the benefits and risks of dosing schedules, can plan appropriate dosing schedules, and is able to explain them to the primary team and the patient
- Dosing in renal failure, during various renal replacement therapies and during extracorporeal membrane oxygenation, in nebulizators
- Knows how to adjust the dose of antimicrobials according to the changes in pharmacokinetic of antibiotics related to the patient condition (decreased renal and hepatic function, severe burns, oedema, etc.)
- Therapeutic drug monitoring (TDM): understands the need for TDM, knows how the interpret the results, and as a leader is capable of organizing TDM in the setting
- Knows and understands the statistical methods for the analysis of AMS interventions
- Knows the IT resources available outside the workplace that may be useful for AMS and knows how to use them
- Knows how to use IT support available in the setting to monitor and improve antimicrobial use
- Knows and understands the use of information technology in surveillance, medication management, and AMS interventions (education, restrictions, drug approval)
- Knows and understands the use of electronic clinical decision support, telehealth, and smartphone apps in antibiotic prescribing and AMS
- Understands the benefits of computerized medical records including computerized prescribing of antimicrobials and contributes to the development and use of the programs
Preliminary programme
Date: 26-27 October 2023
Location: Online
Organisers
Faculty of medicine, University Ss Cyril and Methodius Skopje & Institute for Social Innovation - Skopje
Module objectives
1. Recognizes problems that should be addressed in outpatient setting and is capable for addressing them by organizing appropriate structures, interventions, and monitoring
2. Understands the role of cultural and behavioral determinants in antibiotic prescribing in outpatient and primary care
3. Can recognize the facilitators and barriers to ASPs and is able to address them
4. Understands and can perform different communication techniques
5. Can communicate with all stakeholders involved in AMS at primary care level
Preliminary programme
Date: 13-14 March, 2024
Location: Online
Organisers
ESCMID PK/PD of Anti-Infectives Study Group (EPASG), The European Committee on Antimicrobial Susceptibility Testing (EUCAST), The International Society of Anti-Infective Pharmacology (ISAP)
Module objectives
This course presents and summarises currently available knowledge on PK/PD of
commonly used antibiotics, strategies for setting clinical breakpoints, individualised dosing, and
therapeutic drug monitoring. The aim is to provide participants with insights that can be used to
optimise antibiotic therapy for different patient groups, infection sites and pathogens.
Preliminary programme
*This module programme is subject to minor amendments
Date: 5-6 April 2024
Location: Online
Organisers
Aster Medcity
Module objectives
At the end of the course, the participant will be able to:
- Understand the basics and need for AMS in their setting
- Develop and implement a AMS program relevant to their setting
Preliminary programme
*This module programme is subject to minor amendments
CMI Website
eAcademy
EUCAST
